Therapeutic Cancer Vaccines: A Tale of Three Vaccines

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 182 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Cancer Vaccines: Milestones, Promises, Opportunities, and Challenges. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Cancer Vaccines: Milestones, Promises, Opportunities, and Challenges (online CE course)
Therapeutic Cancer Vaccines: A Tale of Three Vaccines

Previously, HPV and hepatitis B vaccines that aim to prevent virus infection and reduce the high risks associated with viral infection-induced cancer were discussed. In addition to these cancer preventive vaccines, there are also FDA-approved therapeutic cancer vaccines for cancer treatment. These include vaccines against prostate cancer, bladder cancer, and melanoma.